toronto institute of pharmaceutical sciences
  • Join Our Forum
  • Online Exam Prep
  • Enroll Now
  • HOME
  • ABOUT US
  • WHY TIPS?
  • COURSES
    • »  Evaluating Exams
    • »  Qualifying Exams Part I (MCQ)
    • »  Qualifying Exams Part II (OSCE)
    • »  Technicians Evaluating Exams
    • »  Technician Qualifying Exams
    • »  Technician OSPE
    • »  FPGEE Exam
    • »  NAPLEX
  • FACILITIES
    • »  Financial Assistance
    • »  Guest house
    • »  Student Jobs
    • »  Online Lectures
    • »  Books for sale
  • TESTIMONIALS
  • CAREERS
  • CONTACT US
Pharmacy Prep Evaluating Exam Review & Guide - Dr. Misbah Biabani, Ph.D.

Pharmacy Qualifying Exam 1

Book Contents:Qualifying Exam Review

Module 1: Professional Ethics and Regulations 8%

  • Chapter 1 Healthcare System in Canada
  • Chapter 2 National Association of Pharmacy Regulatory Authority
  • Chapter 3 Health Canada
  • Chapter 4 Federal Regulations
  • Chapter 5 Narcotics Regulations
  • Chapter 6 Benzodiazepines and other Targeted Substances Regulations
  • Chapter 7 Control Substances
  • Chapter 8 Ethical Principles
  • Chapter 9 Pharmacoeconomics
  • Chapter 10 Patient Care

Module 2: Patient Care 52%

    PSYCHIATRIC DISORDERS
  • Chapter 11 Depressive Disorders
  • Chapter 12 Anxiety Disorders
  • Chapter 13 Psychosis
  • Chapter 14 Dementia Disorders
  • Chapter 15 Attention Deficit Hyperactivity Disorder
  • Chapter 16 Sleep Related Disorders

  • NEUROLOGICAL DISORDERS
  • Chapter 17 Epilepsy
  • Chapter 18 Parkinson’s Disease
  • Chapter 19 Headaches
  • Chapter 20 Chronic Pain

  • OPHTHALMIC DISORDERS
  • Chapter 21 Minor Ailment Eye Conditions
  • Chapter 22 Glaucoma
  • Chapter 23 Conjunctivitis

  • ENDOCRINE DISORDERS
  • Chapter 24 Diabetes Mellitus
  • Chapter 25 Thyroid Disorders
  • Chapter 26 Contraception’s

  • CARDIOVASCULAR DISORDERS
  • Chapter 27 Hypertension
  • Chapter 28 Dyslipidemia
  • Chapter 29 Angina
  • Chapter 30 Acute Coronary Syndrome
  • Chapter 31 Post Myocardial Infarction
  • Chapter 32 Stroke
  • Chapter 33 Congestive Heart Failure
  • Chapter 34 Arrhythmias
  • Chapter 35 Peripheral Vascular Disorders
  • Chapter 36 Anemia and supplements

  • RESPIRATORY DISORDERS
  • Chapter 37 Asthma
  • Chapter 38 Chronic Obstructive Pulmonary Disease
  • Chapter 39 Croup
  • Chapter 40 Minor Ailment Respiratory Tract Symptoms Assessment
  • Chapter 41 Allergic Rhinitis and Drug Allergies
  • Chapter 42 Cough, Cold and Congestion, Fever

  • GASTROINTESTINAL DISORDERS
  • Chapter 43 Minor Ailment, GI symptoms Assessment
  • Chapter 44 Peptic Ulcer
  • Chapter 45 Inflammatory Bowel Disease
  • Chapter 46 Irritable Bowel Syndrome
  • Chapter 47 Minor Ailment, Constipation
  • Chapter 48 Minor Ailment, Hemorrhoids
  • Chapter 49 Minor Ailment, Diarrhea
  • Chapter 50 Nausea and Vomiting

  • DRUGS IN LIVER AND RENAL DISORDERS
  • Chapter 51 Liver Diseases and Hepatitis Infections
  • Chapter 52 Chronic Kidney Disease

  • REPRODUCTIVE, GYNECOLOGICAL AND GENITOURINARY DISORDERS
  • Chapter 53 Drug in pregnancy and Lactations
  • Chapter 54 Endometriosis
  • Chapter 55 Impotence and Sexual Dysfunction
  • Chapter 56 Menopause
  • Chapter 57 Toxic Shock Syndrome
  • Chapter 58 Benign Prostate Hyperplasia
  • Chapter 59 Minor Ailments Assessment Gynecology and Genitourinary Conditions
  • Chapter 60 Vaginal Infections
  • Chapter 61 Urinary Incontinence

  • MUSCULOSKELETAL DISORDERS
  • Chapter 62 Osteoarthritis
  • Chapter 63 Rheumatoid Arthritis
  • Chapter 64 Gout Arthritis
  • Chapter 65 Osteoporosis
  • Chapter 66 Minor Ailment Pain Assessment

  • DERMATOLOGICAL DISORDERS
  • Chapter 67 Acne
  • Chapter 68 Rosacea
  • Chapter 69 Dermatitis
  • Chapter 70 Minor Ailment Foot Conditions
  • Chapter 71 Psoriasis
  • Chapter 72 Sun Burn
  • Chapter 73 Minor Ailment Mouth Conditions
  • Chapter 74 Head Lice and Scabies

  • INFECTIONS DISEASES
  • Chapter 75 Spectrum of Antibiotics used in Infectious Diseases
  • Chapter 76 Endocarditis
  • Chapter 77 Acute Otitis Media in Children
  • Chapter 78 Upper respiratory tract infections Streptococcal Sore throat, Sinusitis, and acute bronchitis
  • Chapter 79 Influenza
  • Chapter 80 Community Acquired Pneumonia
  • Chapter 81 Tuberculosis
  • Chapter 82 Bacterial Meningitis
  • Chapter 83 Skin and Bone & Joints Infections Acute Osteomyelitis
  • Chapter 84 Septic Shock
  • Chapter 85 Urinary Tract Infections (cotrimoxazole, nitrofurantoin)
  • Chapter 86 Sexually Transmitted Diseases
  • Chapter 87 Herpes Viral Infections (famciclovir, acyclovir, valacyclovir)
  • Chapter 88 HIV infections (combo NNRTI + 2NRTI)
  • Chapter 89 Travellers’ Diarrhea
  • Chapter 90 Malaria Prevention
  • Chapter 91 Lyme Disease
  • Chapter 92 Fluid and Electrolyte Disorders
  • Chapter 93 Chemotherapy Side Effects Management

Module 3: Product Distribution 19%

  • Chapter 94 Medication Orders and Dosage Forms
  • Chapter 95 Basic Pharmacy Math
  • Chapter 96 Dosage Calculations
  • Chapter 97 Dilutions and Concentrations
  • Chapter 98 Electrolyte Solutions
  • Chapter 99 Compounding and Reconstitutions
  • Chapter 100 Clinical Pharmacokinetics
  • Chapter 101 Drug Distribution Systems
  • Chapter 102 Formulary System
  • Chapter 103 Medication Handling & Storage Conditions
  • Chapter 104 Sterile Preparations
  • Chapter 105 Hospital Organization and Committees
  • Chapter 106 Drug Supply Chain

Module 4: Practice Setting 3%

  • Chapter 107 Pharmacy Management
  • Chapter 108 Financial Management
  • Chapter 109 Business Math
  • Chapter 110 Human Resources Management
  • Chapter 111 Inventory Management
  • Chapter 112 Marketing Pharmaceutical Services
  • Chapter 113 Workplace Safety and Risk Management

Module 5: Health Promotion 3%

  • Chapter 114 Health Promotion and Education
  • Chapter 115 Drug Withdrawal Symptoms and Management
  • Chapter 116 Smoking Cessation
  • Chapter 117 Drugs in Elderly Populations
  • Chapter 118 Clinical Toxicity
  • Chapter 119 Immunization and vaccines
  • Chapter 120 Travel Medicine

Module 6: Knowledge and Research Application 6%

  • Chapter 121 Pharmaceutical Literature
  • Chapter 122 Canadian Clinical Resources
  • Chapter 123 Pharmacy Practice Information Resources
  • Chapter 124 Pharmacoepidemiology
  • Chapter 125 Biostatistics
  • Chapter 126 Screening for Disease
  • Chapter 127 Clinical Resources
  • Chapter 128 Critical Appraisal of Literature

Module 7: Communication and Education 4%

  • Chapter 129 Verbal and Non-Verbal Communication Skills
  • Chapter 130 Promoting Medication Adherence
  • Chapter 131 Patient Health Care Behavior
  • Chapter 132 Communication Stages in Pharmacy Practice
  • Chapter 133 Drug Dosage Forms
  • Chapter 134 Complimentary and Alternate Therapies
  • Chapter 135 Nutrition and Herbal Products
  • Chapter 136 Patient Education on Home Testing

Module 8: Intra and Inter-Professional Collaboration 6%

  • Chapter 137 Interprofessional collaboration
  • Chapter 138 Community Clinical Pharmacy Practice
  • Chapter 139 Prescription Drug Monitoring Programs
  • Chapter 140 Switching Drug Therapies
  • Chapter 141 Expanded Scope of Pharmacy Practice Services

Part 9: Quality and Patient Safety 5%

  • Chapter 142 Patient Safety Organizations (ISMP)
  • Chapter 143 Quality and Patient Safety
  • Chapter 144 Medication Safety and Incident Reporting
  • Chapter 145 Drug Recalls, Warning and withdrawals
  • Chapter 146 Quality Assurance in Hospital Pharmacy Practice
  • Chapter 147 Chapter Substance Abuse and Management
Go Back to the Course Page

TIPS COLLEGE © 2020

Contact Details


Tel: 416–223–PREP(7737)
Mobile: 647–221–0457
SMS/Text: 647-221-0457
Email: success@pharmacyprep.com

Address


TORONTO CAMPUS:
4750 Yonge St. Unit #129
(Yonge St @ Sheppard Ave E)
Toronto, ON, M2N 5M6
Canada

MISSISSAUGA/BRAMPTON CAMPUS:
7900 Hurontario St. Unit 3
Brampton, ON, L6Y 0P6
Canada

tipscollege.com


Privacy Policy
Shipping/Return Policy
Disclaimer

Follow Us


Forums | Blogs
www.pharmacyprep.com
www.physicianprep.com
www.eprepstation.com
Facebook
Twitter
Instagram